Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 1051-1100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07045311
JS207 Combination Therapy in Triple-negative Breast Cancer
PHASE2Recruiting
80 participants
Started: Sep 17, 2025 · Completed: Mar 22, 2029
1 condition1 sponsor16 locations
NCT07192458
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
PHASE2Recruiting
60 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT07190222
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
PHASE3Recruiting
942 participants
Started: Sep 17, 2025 · Completed: Jan 22, 2030
1 condition1 sponsor13 locations
NCT07169578
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3Recruiting
800 participants
Started: Sep 17, 2025 · Completed: Jun 7, 2028
1 condition1 sponsor11 locations
NCT07023835
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
PHASE2Recruiting
240 participants
Started: Sep 17, 2025 · Completed: Oct 31, 2028
1 condition1 sponsor15 locations
NCT07195162
Validating and Evaluating the Pain Medicine Digital Workflow Algorithm (PGS 1.0)
N/ARecruiting
200 participants
Started: Sep 17, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT07012135
Deciphering Preserved Autonomic Function After Multiple Sclerosis
NARecruiting
13 participants
Started: Sep 17, 2025 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT07179224
EEG Changes After rTMS Stimulation
NARecruiting
15 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06716502
A New Portable Device for Non-invasive Ventilatory Support
NARecruiting
50 participants
Started: Sep 17, 2025 · Completed: Nov 19, 2025
2 conditions3 sponsors3 locations
NCT07053085
A Study of Surgery and Radiotherapy in People With Breast Cancer
PHASE2Recruiting
162 participants
Started: Sep 17, 2025 · Completed: Sep 17, 2029
2 conditions2 sponsors7 locations
NCT06908252
MAPS PrEP Van Study
PHASE4Recruiting
20 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT07161713
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
NARecruiting
100 participants
Started: Sep 17, 2025 · Completed: Sep 30, 2027
11 conditions1 sponsor1 location
NCT07200986
Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
PHASE1Recruiting
218 participants
Started: Sep 17, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor5 locations
NCT07122973
Topographical Distribution of Itch and Pain Receptors
NARecruiting
30 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT06989957
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
PHASE1Recruiting
40 participants
Started: Sep 17, 2025 · Completed: Aug 31, 2029
1 condition2 sponsors1 location
NCT06420531
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
NARecruiting
486 participants
Started: Sep 16, 2025 · Completed: Aug 30, 2030
1 condition1 sponsor4 locations
NCT07113561
Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance
NARecruiting
60 participants
Started: Sep 16, 2025 · Completed: Dec 31, 2027
1 condition5 sponsors1 location
NCT07122895
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
PHASE2Recruiting
90 participants
Started: Sep 16, 2025 · Completed: Mar 31, 2030
1 condition2 sponsors1 location
NCT07001891
Functional Connectivity of the Interoceptive Network in RLS
NARecruiting
30 participants
Started: Sep 16, 2025 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT06589245
Inhaled Ciclesonide Study in Preterm Infants
PHASE1Recruiting
30 participants
Started: Sep 16, 2025 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT07093749
Perspectives on Antibiotics and Tracking Symptoms in Children
NARecruiting
300 participants
Started: Sep 16, 2025 · Completed: Aug 31, 2026
7 conditions2 sponsors1 location
NCT06890403
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
NARecruiting
6,000 participants
Started: Sep 16, 2025 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06181630
A Lactation Study in Women Receiving Treatment With Ozanimod
PHASE4Recruiting
16 participants
Started: Sep 16, 2025 · Completed: Dec 16, 2026
2 conditions1 sponsor1 location
NCT07104162
A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment
PHASE1Recruiting
40 participants
Started: Sep 16, 2025 · Completed: Dec 23, 2026
1 condition3 sponsors2 locations
NCT07207707
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
PHASE1Recruiting
78 participants
Started: Sep 16, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor5 locations
NCT07037758
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
PHASE1Recruiting
380 participants
Started: Sep 16, 2025 · Completed: Jan 4, 2031
1 condition2 sponsors4 locations
NCT07215715
US Benchmarking Clinical Study
N/ARecruiting
150 participants
Started: Sep 16, 2025 · Completed: Jul 31, 2026
5 conditions4 sponsors3 locations
NCT07175623
Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients
NARecruiting
60 participants
Started: Sep 16, 2025 · Completed: Dec 30, 2025
3 conditions1 sponsor2 locations
NCT07190508
Pre-Sedation Fluid Replacement and Duodenal Passage Effects on Intraocular Pressure
N/ARecruiting
40 participants
Started: Sep 16, 2025 · Completed: Oct 16, 2025
2 conditions1 sponsor1 location
NCT07190469
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
PHASE1Recruiting
80 participants
Started: Sep 16, 2025 · Completed: Feb 28, 2029
2 conditions1 sponsor1 location
NCT06263647
Launching the Houston Hospital-Based Violence Intervention Program (Houston-HVIP): Developing and Evaluating a Hospital-Based Intervention to Reduce Recurrent Violence
NARecruiting
274 participants
Started: Sep 16, 2025 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT07169318
First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
PHASE1Recruiting
78 participants
Started: Sep 16, 2025 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT07085923
Norwegian Mental Illness Heart Health Study
NARecruiting
70 participants
Started: Sep 16, 2025 · Completed: Jun 30, 2028
8 conditions1 sponsor1 location
NCT06588556
Improving Needs Among Older Adults
NARecruiting
350 participants
Started: Sep 16, 2025 · Completed: Dec 31, 2028
5 conditions2 sponsors4 locations
NCT07157215
An International Survey on the Use of NIV Outside the ICU
N/ARecruiting
400 participants
Started: Sep 16, 2025 · Completed: Mar 15, 2026
3 conditions4 sponsors1 location
NCT06908824
No Endotamponade for Macular Hole Repair: the NEMAR Study
NARecruiting
180 participants
Started: Sep 16, 2025 · Completed: Dec 31, 2027
2 conditions3 sponsors3 locations
NCT06997081
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
PHASE2Recruiting
104 participants
Started: Sep 16, 2025 · Completed: Sep 30, 2030
1 condition2 sponsors1 location
NCT07091630
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
PHASE3Recruiting
160 participants
Started: Sep 16, 2025 · Completed: Jan 23, 2031
3 conditions1 sponsor1 location
NCT07210125
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
PHASE4Recruiting
75 participants
Started: Sep 16, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT07216183
Epidermal Sensors for Wireless and Enhanced Amputee Skin Tracking (E-SWEAT) Part 1
PHASE1Recruiting
16 participants
Started: Sep 16, 2025 · Completed: Jul 30, 2029
1 condition2 sponsors1 location
NCT07190209
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
PHASE3Recruiting
942 participants
Started: Sep 16, 2025 · Completed: Jan 22, 2030
1 condition1 sponsor11 locations
NCT07215767
Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice
PHASE3Recruiting
850 participants
Started: Sep 16, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor3 locations
NCT07188922
Effect of Transition From Mechanical Ventilation to Spontaneous Breathing on Intraocular Pressure in ICU (VENT-IOP)
N/ARecruiting
40 participants
Started: Sep 16, 2025 · Completed: Oct 16, 2025
1 condition1 sponsor1 location
NCT07168356
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
PHASE1Recruiting
32 participants
Started: Sep 16, 2025 · Completed: Aug 18, 2026
1 condition1 sponsor1 location
NCT07132645
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
EARLY_PHASE1Recruiting
30 participants
Started: Sep 16, 2025 · Completed: Sep 1, 2027
1 condition2 sponsors1 location
NCT07045935
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
PHASE4Recruiting
60 participants
Started: Sep 16, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06910631
Optimizing the Care Pathway of Febrile Children Via Capillary C-reactive Protein Assay in Primary Care
NARecruiting
420 participants
Started: Sep 15, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor16 locations
NCT06856044
Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy
NARecruiting
30 participants
Started: Sep 15, 2025 · Completed: Mar 31, 2028
1 condition1 sponsor2 locations
NCT07160231
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
PHASE4Recruiting
200 participants
Started: Sep 15, 2025 · Completed: May 1, 2028
3 conditions2 sponsors7 locations
NCT07155239
1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)
PHASE1Recruiting
30 participants
Started: Sep 15, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location